Gilliland, Frank D., MD, MPH, PhD

EDUCATION

B.A. (Physics/Mathematics) 1973, University of Virginia
M.S. (Physics) 1974, University of Virginia
M.D. (Medicine) 1977, University of Virginia
M.P.H. (Occupational/Environmental Health) 1990, University of Minnesota
Ph.D. (Environmental/Occupational Epidemiology) 1992, University of Minnesota

 

PROFESSIONAL CERTIFICATION
American Board of Emergency Medicine, 1985
American Board of Preventive Medicine, Occupational and Environmental
     Section, 1994

 

EMPLOYMENT

2/07 - Present Adjunct Senior Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
2006 - Present Director, Southern California Environmental Health Sciences Center
2003 - Present Director, Children's Environmental Health Center
2002 - 1/07 Adjunct Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
2002 - Present Professor, Department of Preventive Medicine, Division of Occupational and Environmental Health, University of Southern California, Los Angeles, CA
1997 - 2002 Associate Professor, Department of Preventive Medicine, Division of Occupational and Environmental Health, University of Southern California, Los Angeles, CA
1995 - 1997 Assistant Professor, Department of Internal Medicine, Epidemiology and Cancer Control, University of New Mexico, Albuquerque, NM
1994 - 2002 Adjunct Associate Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
1992 - 1995 Research Assistant Professor, Epidemiology and Cancer Control Program, New Mexico Tumor Registry, University of New Mexico, Albuquerque, NM
1992 Fellowship, Midwest Center for Occupational Health and Safety, University of Minnesota, Minneapolis, MN
1990 - 1991 Resident, Occupational Medicine, St. Paul-Ramsey Medical Center, St. Paul, MN

 

HONORS
Echols Scholar, University of Virginia, 1969-1973
Fellow, American College of Emergency Physician, 1985
Delta Omega member, 1990

 

AREAS OF RESEARCH
Dr. Gilliland's primary research focus is the molecular epidemiology of respiratory health. His current research program includes studies of asthma etiology and exacerbation, lung function growth in children, respiratory illness-related school absenteeism, and lung cancer etiology and early detection. He leads a major effort to understand susceptibility to the adverse respiratory effects of ambient and indoor air pollution and smoking. 



REPRESENTATIVE PUBLICATIONS

  1. Crowell, R. E., F. D. Gilliland, R. T. Temes, H. J. Harms, R. E. Neft, E. Heaphy, D. H. Auckley, L. A. Crooks, S. W. Jordan, J. M. Samet, J. F. Lechner and S. A. Belinsky: Detection of Trisomy 7 in Nonmalignant Bronchial Epithelium from Lung Cancer Patients and Individuals at Risk for Lung Cancer. Cancer Epidemiol. Biomarkers Prev. 5: 631-637, 1996.

     

  2. Lechner, J. F., R. E. Neft, F. D. Gilliland, R. E. Crowell and S. A. Belinsky: Molecular Identification of Individuals at High Risk for Lung Cancer. Radiat. Oncol. Investig. 5: 103-105, 1997.

     

  3. Neft, R. E., M. M. Murphy, L. A. Tierney, S. A. Belinsky, M. Anderson, G. Saccomanno, R. Michels, S. Timm, F. D. Gilliland, R. E. Crowell and J. F. Lechner: Concurrent Fluorescence In Situ Hybridization and Immunocytochemistry for the Detection of Chromosome Aberrations in Exfoliated Bronchial Epithelial Cells. Acta Cytol. 41: 1769-1773, 1997.

     

  4. Tierney, L. A., R. E. Neft, S. A. Belinsky, F. T. Lauer, F. D. Gilliland, R. E. Crowell and J. F. Lechner: Double-Label Suspension Immunocytochemistry for Detection of Gene Dysfunction in Sputum. J. Histotechnology 20: 13-17, 1997.

     

  5. Lechner, J. F., R. E. Neft RE, F. D. Gilliland, R. E. Crowell, D. H. Auckley, R. T. Temes and S. A. Belinsky: Individuals at High Risk for Lung Cancer Have Airway Epithelial Cells with Chromosome Aberrations Frequently Found in Lung Tumor Cells. In Vivo 12: 23-26, 1998.

     

  6. Neft, R. E., R. E. Crowell, F. D. Gilliland, M. M. Murphy, J. L. Lane, H. Harms, T. Coons, E. Heaphy, S. A. Belinsky and J. F. Lechner: Frequency of Trisomy 20 in Nonmalignant Bronchial Epithelium from Lung Cancer Patients and Cancer-Free Former Uranium Miners and Smokers. Cancer Epidemiol. Biomarkers Prev. 7: 1051-1054, 1998.

     

  7. Palmisano, W. A., K. K. Divine, G. Saccomanno, F. D. Gilliland, S. B. Baylin, J. G. Herman and S. A. Belinsky: Predicting Lung Cancer by Detecting Aberrant Promoter Methylation in Sputum. Cancer Res. 60: 5954-5958, 2000.

     

  8. Auckley, D. H., R. E. Crowell, E. R. Heaphy, C. A. Stidley, J. F. Lechner, F. D. Gilliland and S. A. Belinsky: Reduced DNA-Dependent Protein Kinase Activity is Associated with Lung Cancer. Carcinogenesis 22: 723-727, 2001.

     

  9. Divine, K. K., F. D. Gilliland, R. E. Crowell, C. A. Stidley, T. J. Bocklage, D. L. Cook and S. A. Belinsky: The XRCC1 399 Glutamine Allele is a Risk Factor for Adenocarcinoma of the Lung. Mutat. Res. 461: 273-278, 2001.

     

  10. Belinsky, S. A., W. A. Palmisano, F. D. Gilliland, L. A. Crooks, K. K. Divine, S. A. Winters, M. J. Grimes, H. J. Harms, C. S. Tellez, T. M. Smith, P. P. Moots, J. F. Lechner, C. A. Stidley and R. E. Crowell: Aberrant Promoter Methylation in Bronchial Epithelium and Sputum from Current and Former Smokers.Cancer Res. 62: 2370-2377, 2002.

     

  11. Gilliland, F. D., H. J. Harms, R. E. Crowell, Y. F. Li, R. Willink and S. A. Belinsky: Glutathione-S-transferase P1 and NADPH Quinone Oxidoreductase Polymorphisms are Associated with Aberrant Promoter Methylation of P16INK4a and O6-Methylguanine-DNA Methyltransferase in Sputum. Cancer Res. 62: 2248-2252, 2002.

     

  12. Pulling, L. C., K. K. Divine, D. M. Klinge, F. D. Gilliland, T. Kang, A. G. Schwartz, T. J. Bocklage and S. A. Belinsky: Promoter Hypermethylation of the O6-Methylguanine-DNA Methyltransferase Gene: More Common in Lung Adenocarcinomas from Never-Smokers than Smokers and Associated with Tumor Progression. Cancer Res. 63: 4842-4848, 2003.

     

  13. Belinsky, S. A., D. M. Klinge, K. D. Liechty, T. H. March, T. Kang, F. D. Gilliland, N. Sotnic, G. Adamova, G. Rusinova and V. Telnov: Plutonium Targets the p16 Gene for Inactivation by Promoter Hypermethylation in Human Lung Adenocarcinoma. Carcinogenesis 25: 1063-1067, 2004.

     

  14. Belinsky, S. A., D. M. Klinge, J. D. Dekker, M. W. Smith, T. J. Bocklage, F. D. Gilliland, R. E. Crowell, D. D. Karp, C. A. Stidley and M. A. Picchi: Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk. Clin. Cancer Res. 11: 6505-6511, 2005.

     

  15. Divine, K. K., L. C. Pulling, P. G. Marron-Terada, K. C. Liechty, T. Kang, A. G. Schwartz, T. J. Bocklage, T. A. Coons, F. D. Gilliland and S. A. Belinsky: Multiplicity of Abnormal Promoter Methylation in Lung Adenocarcinomas from Smokers and Never Smokers. Int. J. Cancer 114: 400-405, 2005.

     

  16. Tesfaigzi, Y., O. B. Myers, C. A. Stidley, K. Schwalm, M. Picchi, R. E. Crowell, F. D. Gilliland and S. A. Belinsky: Genotypes in Matrix Metalloproteinase 9 are Risk Factors for Chronic Obstructive Pulmonary Disease. Exp. Lung Res. 31(Suppl. 1): 74-75, 2005.
Home    Animal Respect Code    Site Map    Employee Links    Contact
© 2008 - 2012 Lovelace Respiratory Research Institute